Twist Bioscience (TWST) Other Accumulated Expenses (2018 - 2026)

Twist Bioscience (TWST) has reported Other Accumulated Expenses for 9 consecutive years, with $59.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Accumulated Expenses rose 438.98% year-over-year to $59.7 million in Q2 2026; TTM through Jun 2026 was $59.7 million, a 438.98% increase from a year earlier, with the FY2025 full-year figure at $35.2 million, up 505.16% from the prior year.
• Other Accumulated Expenses was $59.7 million for Q2 2026 at Twist Bioscience, down from $67.8 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $67.8 million in Q1 2026 and troughed at $5.2 million in Q4 2024.
• A 5-year average of $17.9 million and a median of $10.6 million in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses tumbled 60.47% in 2023 and jumped 841.68% in 2026, its largest moves.
• Over 5 years, Other Accumulated Expenses stood at $15.8 million in 2022, then plunged by 59.44% to $6.4 million in 2023, then decreased by 18.32% to $5.2 million in 2024, then surged by 156.89% to $13.5 million in 2025, then jumped by 343.36% to $59.7 million in 2026.
• The last three Other Accumulated Expenses figures came in at $59.7 million (Q2 2026), $67.8 million (Q1 2026), and $13.5 million (Q4 2025), per Business Quant data.